About Diffinity Genomics
Diffinity Genomics is a company based in West Henrietta (United States) founded in 2005 was acquired by Chiral Technologies in August 2015. Diffinity Genomics has raised $1.36 million across 9 funding rounds from investors including HHS, Chiral Technologies and Mass Medical Angels. Diffinity Genomics operates in a competitive market with competitors including DnaNudge, Purigen Biosystems, Stratec Biomedical, Synplogen and Advanced Analytical Technologies, among others.
- Headquarter West Henrietta, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.36 M (USD)
in 9 rounds
-
Latest Funding Round
$99.65 K (USD), Grant
Aug 15, 2012
-
Investors
HHS
& 2 more
-
Employee Count
Not available
-
Acquired by
Chiral Technologies
(Aug 03, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Diffinity Genomics
Diffinity Genomics has successfully raised a total of $1.36M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $99.65 thousand completed in August 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Diffinity Genomics
Diffinity Genomics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Chiral Technologies and Mass Medical Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed stage investments are made in life sciences and healthcare.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Advanced chirality products and custom purification services
|
Locked | Locked | Locked |
Investor details for Diffinity Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diffinity Genomics
Investment portfolio details for Diffinity Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diffinity Genomics
Detailed financials for Diffinity Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diffinity Genomics Comparisons
Peer comparison for Diffinity Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diffinity Genomics
Diffinity Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DnaNudge, Purigen Biosystems, Stratec Biomedical, Synplogen and Advanced Analytical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Lab-on-chip wearable systems for genetic diagnosis are provided.
|
|
| Locked | Locked | Locked |
Isotachophoresis technology is provided for nucleic acid sample preparation.
|
|
| Locked | Locked | Locked |
Provider of automated analyzer systems, data management software, and solutions for IVD sample preparation
|
|
| Locked | Locked | Locked |
DNA synthesis technology is developed using microbial methods.
|
|
| Locked | Locked | Locked |
Instruments, software, and services for scientific laboratory management are provided.
|
Detailed competitors of Diffinity Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diffinity Genomics
Complete news archive for Diffinity Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diffinity Genomics
Diffinity Genomics was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Diffinity Genomics is headquartered in West Henrietta, United States. It is registered at West Henrietta, New York, United States.
Diffinity Genomics is a funded company, having raised a total of $1.36M across 9 funding rounds to date.
Diffinity Genomics was founded in 2005 and is based in West Henrietta, United States. Operations are centered in the genomics sector, where tools and methods for DNA amplification and analysis are provided. Services support research in molecular biology, with products accessible via diffinitygenomics.com. The focus remains on practical applications for scientific and diagnostic workflows in biotechnology.
Diffinity Genomics's top competitors include Stratec Biomedical, Purigen Biosystems and Advanced Analytical Technologies.
Diffinity Genomics has 3 investors. Key investors include HHS, Chiral Technologies, and Mass Medical Angels.